Trastuzumab in combination with different first-line chemotherapies for treatment of HER2-positive metastatic gastric or gastro- oesophageal junction cancer: Updated findings from the German non-interventional study HerMES - Al-Batran, S E; Hannig, C V; Hamm, T (European Journal of Cancer 51 (444))
et al.